Mesenchymal stem cells suppressed skin and lung inflammation and fibrosis in topoisomerase I-induced systemic sclerosis associated with lung disease mouse model-Reference-Cited by-同舟云学术

Mesenchymal stem cells suppressed skin and lung inflammation and fibrosis in topoisomerase I-induced systemic sclerosis associated with lung disease mouse model

Published:2022-11-30 Issue:2 Volume:391 Page:323-337
ISSN:0302-766X
Container-title:Cell and Tissue Research
language:en
Short-container-title:Cell Tissue Res

Author:

Ganesan Nithya,Chang Yu-Di,Hung Shih-Chieh,Lan Joung-Liang,Liao Jiunn-Wang,Fu Shih Tsung,Lee Chen-Chen^ORCID

Funder

Ministry of Education (MOE) in Taiwan

China Medical University Taiwan

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00441-022-03716-8.pdf

Reference49 articles.

1. Boonstra M, Bakker JA, Grummels A, Ninaber MK, Marsan NA, Wortel CM, Huizinga TWJ, Jordan S, Hoffman-Vold AM, Distler O, Toes REM, Scherer HU, de Vries-Bouwstra JK (2020) Association of anti-topoisomerase I antibodies of the IgM isotype with disease progression in anti-topoisomerase I-positive systemic sclerosis. Arthritis Rheumatol 72:1897–1904

2. Brembilla NC, Montanari E, Truchetet ME, Raschi E, Meroni P, Chizzolini C (2013) Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts. Arthritis Res Ther 15(5)

3. Chang YD, Li CH, Tsai CH, Cheng YW, Kang JJ, Lee CC (2020) Aryl hydrocarbon receptor deficiency enhanced airway inflammation and remodeling in a murine chronic asthma model. Faseb J 34:15300–15313

4. Chizzolini C, Parel Y, Scheja A, Dayer JM (2006) Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts. Arthritis Res Ther 8:R10

5. Cipriani P, Di Benedetto P, Liakouli V, Del Papa B, Di Padova M, Di Ianni M, Marrelli A, Alesse E, Giacomelli R (2013) Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. Clin Exp Immunol 173:195–206

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex differences in CXCL4‐mediated lung damage in the bleomycin‐induced systemic sclerosis mice model;Rheumatology & Autoimmunity;2024-06-28

2. Mesenchymal stromal cell-based therapy in lung diseases; from research to clinic;American Journal of Stem Cells;2024

3. Emerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approaches;Current Opinion in Rheumatology;2023-08-29

4. Research progress on mesenchymal stem cells and their exosomes in systemic sclerosis;Frontiers in Pharmacology;2023-08-25

5. Potential Value of FAPI PET/CT in the Detection and Treatment of Fibrosing Mediastinitis: Preclinical and Pilot Clinical Investigation;Molecular Pharmaceutics;2023-07-24